Enlight Medical was founded in Boston, Massachusetts, the United States. It is a stable and rapidly growing global medical technology company, focusing on interventional medical devices for structural heart diseases and intravascular diseases, as well as neuromodulation products. The company has established R&D centers or production bases in Boston, San Francisco, Shanghai, Beijing and Shenzhen, and all of its production workshops comply with GMP standards.

The R&D and production teams of Enlight Medical have more than 15 years of experience in the R&D and production management of medical devices. It possesses a comprehensive technological platform spanning passive, active, and AI imaging technologies, which can be expanded to the treatment of various cardiovascular and cerebrovascular diseases.

Currently, the company holds multiple medical licenses, and several high-end medical device products at the international advanced level are either undergoing clinical trials or have been submitted for registration review.

The company has successively obtained financing support from well-known investment institutions such as Hillhouse Capital, the State Development and Investment Corporation, Qianhai Mother Fund, etc.

Enlight Medical will always uphold the spirit of benevolence, base itself in China and look to the world, aiming to become a world-class technology provider and product manufacturer of innovative medical devices.